66Th annual meeting società italiana di cancerologia integrating evolution, ecosystems and emerging technologies to transform cancer therapy
Convegno internazionale residenziale (7-9 ott. 2026, Roma) della Società Italiana di Cancerologia per oncologi e ricercatori. Integra biologia evolutiva tumorale, ecosistemi del cancro, AI multimodale, omics spaziale, liquid biopsy, vaccini tumorali e terapie di precisione. Quota: 620 €.
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
Razionale scientifico
Cancer is a dynamic and evolving disease. Its initiation, progression, immune escape, and therapy resistance are driven by complex biological, molecular, and ecological forces, creating a constantly shifting landscape that challenges modern oncology. Understanding and intervening in this complexity requires integrating evolutionary biology, tumor ecosystem analysis, and state-of-the-art technologies together with novel approaches of precision oncology. The scientific program of the 66th Annual Meeting of the Italian Cancer Society is designed to reflect this conceptual shift and bring together clinical and preclinical researcher to discuss the most novel and compelling evidences that might help in designing more active and less toxic treatments. The meeting will be therefore of interest for both preclinical and clinical researchers, working in different areas of cancer research. Over three days the scientific program will see the participation of Italian and foreign world-renowned scientist to integrate clinical and preclinical presentations on different pathologies including but not limited to women (breast and gynecological), gastrointestinal, prostate, lung and pancreatic cancers. This meeting brings together evolutionary biology, technology, and clinical innovation to redefine how we understand and treat cancer. We will examine tumor evolution and ecosystems, revealing how microenvironmental pressures shape heterogeneity, immune escape, metastasis, and resistance. We will showcase transformative technologies — multimodal AI, spatial omics, digital twins, liquid biopsies, and advanced imaging — that are reshaping how cancer is mapped, modeled, and predicted, accelerating translation to the clinic. Finally, we will discuss of precision oncology, focusing on adaptive therapies, rational combinations, and biomarker-driven strategies that exploit tumor vulnerabilities uncovered by evolutionary and multi-omic insights. On the opening day SIC will hold an open session dedicated to survivors, patients, caregivers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients' quality of life.
Luogo
Centro Congressi Europa, Università Cattolica
Largo Francesco Vito 1, Roma (RM)
Programma
WEDNESDAY, OCTOBER 7TH· Centro Congressi Europa, Università Cattolica, Largo Francesco Vito 1, Roma
- 9.30–10.30Registration
- 13.30–14.00Opening Address
- 14.00–14.30Opening Lecture: Evolutionary characterisation of lung cancer metastasisMariam Jamal-Hanjani
- 14.30–16.00Lecture 1: When mistranslation meets cancer immunotherapyReuven Agami
- 15.00–15.15Selected abstract 1
- 15.15–15.30Selected abstract 2
- 15.30–16.00Lecture 2: Integrating multiple dimensions to understand cancer evolutionElisa Oricchio
- 17.00–17.30Coffee Break
- 17.30–19.00The EMBO Keynote Lecture: Metabolic & Epigenetic Control of Cancer ImmunityMassimiliano Mazzone
- 18.00–18.15Selected abstract 3
- 18.15–18.30Selected abstract 4
- 18.30–19.00Lecture 4: Fibroblast remodeling in inflammation and cancerRuth Scherz-Shouval
THURSDAY, OCTOBER 8TH· Centro Congressi Europa, Università Cattolica, Largo Francesco Vito 1, Roma
- 10.30–12.00Lecture 5: Decoding Tumour Ecosystems through Spatial Multi-Omics and Self-Supervised AIJohn Le Quesne
- 11.00–11.15Selected abstract 5
- 11.15–11.30Selected abstract 6
- 11.30–12.00Lecture 6: Tracking cancer initiation in the kidney via somatic mutation analysis of normal cellsIrene Franco
- 13.15–14.45Lunch
- 14.45–16.15Lecture 7: On novel cancer Immunotherapy combinations in a quest for synergyIgnacio Melero
- 15.15–15.30Selected abstract 7
- 15.30–15.45Selected abstract 8
- 15.45–16.15Lecture 8: Immune ecosystems in breast cancer: tumor microenvironment and response to therapySherene Loi
- 16.15–17.00Prodi LecturePaolo Di Fiore
- 17.00–17.30Coffee Break
- 17.30–19.00Lecture 9: Functionalizing tumor complexity in pancreatic cancerGiannicola Genovese
- 18.00–18.15Selected abstract 9
- 18.15–18.30Selected abstract 10
- 18.30–19.00Lecture 10: From Molecular Landscape to Clinical Precision: Navigating Colorectal Cancer Subtypes and Therapeutic FrontiersErica Martinelli
FRIDAY, OCTOBER 9TH· Centro Congressi Europa, Università Cattolica, Largo Francesco Vito 1, Roma
- 8.00–9.00Registration
- 9.00–10.30Lecture 11: Implementation of ctDNA testing in clinical and translational researchNicola Normanno
- 9.30–9.45Selected abstract 11
- 9.45–10.00Selected abstract 12
- 10.00–10.30Lecture 12: CtDNA in localized colon cancer: scientifically sound or clinically useful?Chiara Cremolini
- 10.30–11.00Coffee break
- 12.30–13.45Lunch
- 13.45–15.15Lecture 13: Exploring Multi-Target Addiction in Lung Cancer: What's Next?Sara Pilotto
- 14.15–14.30Selected abstract 13
- 14.30–14.45Selected abstract 14
- 14.45–15.15Lecture 14: Cancer Vaccines: The Next Frontier of ImmunotherapyPaolo Ascierto
- 16.15–16.45Closing Lecture: Extrachromosomal DNA (ecDNA): Cancer's Dynamic Circular GenomePaul Salomon Mischel
- 16.45–17.00Closing Remarks
Responsabili del corso
MEETING SRL
Provider
ID Provider: N° 7194
Città: Udine (UD)
Tipologia: Società, Agenzie Ed Enti Privati
Stato accreditamento: Standard
Prof. Carmine Carbone
Responsabile scientifico
Specializzazione: Oncologia medica
Struttura: Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Ruolo: Ricercatore e Medico Oncologo
Con il contributo non vincolante di
- MSD ITALIA
- PIERRE-FABRE
- BRISTOL MYERS SQUIBB
- BAYER
- ASTRAZENECA
Domande frequenti
L'evento è accreditato per: Medico Chirurgo (Farmacologia E Tossicologia Clinica, Medicina Nucleare); Farmacista (Farmacista Pubblico Del Ssn); Medico Chirurgo (Oncologia, Genetica Medica, Patologia Clinica (Laboratorio Di Analisi Chimico-Cliniche E Microbiologia), Medicina Interna, Chirurgia Generale, Biochimica Clinica, Laboratorio Di Genetica Medica, Radiodiagnostica, Medicina Generale (Medici Di Famiglia), Ematologia, Anatomia Patologica).
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.